Given that Ki-67 is known to identify cancers that are sensitive to chemotherapeutic agents that target proliferating cells13,14, in this study we hypothesized that DKI may be able to predict the response of HGSOC to chemotherapy drugs that inhibit cell division like carboplatin and paclitaxel. This evidence concerns the gene MKI67 and cancer.